| 18 U.S. Code § 1001 - Statements or entries generally |
| A Report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 Messenger Ribonucleic Acid (mRNA) Biologicals |
| About VAERS (Vaccine Adverse Event Reporting System) |
| Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia |
| All Deaths Reported to VAERS by Year |
| Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim: Results and Analysis |
| Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches |
| APPENDIX 2.2: Cumulative and Interval Summary Tabulation of Serious and Non-Serious Adverse Reactions from Post-Marketing Data Sources |
| Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine in the United States |
| BNT162b2 Vaccine-Associated Myo/Pericarditis in Adolescents: A Stratified Risk-Benefit Analysis |
| CDC Admits It Never Monitored VAERS for COVID Vaccine Safety Signals |
| CDC Finally Released Its VAERS Safety Monitoring Analyses for COVID Vaccines via FOIA |
| Congressional testimony on Surveillance Systems for Adverse Events and Medical Errors |
| COVID vaccination and age-stratified all-cause mortality risk |
| COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1 |
| COVID-19 Vaccine Lots |
| Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997– 2013 |
| Delayed Vigilance: A Comment on Myocarditis in Association with the COVID-19 Injections |
| Electronic Support for Public Health–Vaccine Adverse event Reporting System (ESP:VAERS) |
| Estimating the number of COVID vaccine deaths in America |
| EudraVigilance |
| Evaluating Data Integrity and Reporting Challenges in Public Health: Lessons from COVID-19 Data Collection in Washington State |
| Frequency and Associations of Adverse Reactions of COVID19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States |
| How COVID Shots Suppress Your Immune System |
| Is the US’s Vaccine Adverse Event Reporting System broken? |
| MedAlerts.org - Search the U.S. Government's VAERS Data |
| New VAERS analysis reveals hundreds of serious adverse events that the CDC and FDA never told us about |
| OpenVAERS |
| Patient Betrayal: The Corruption of Healthcare, Informed Consent and the Physician-Patient Relationship |
| Report an Adverse Event to VAERS |
| Safety of mRNA Vaccines Administered During the First Twenty-Four Months of the International COVID-19 Vaccination Program |
| Safety Signals for COVID Vaccines Are Loud and Clear. Why Is Nobody Listening? |
| Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System |
| Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination |
| Tawny Buettner, RN, observed a 10X increase in the rate of myocarditis after the vaccines rolled out |
| The Defender Show: Vaccine Safety Advocate Tells RFK Jr.: VAERS Protects Vaccine Makers, Not Kids |
| The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990–1997 |
| The Vaccine Injury Compensation Program: Addressing Needs and Improving Practices |
| Urgent Open Letter to the EMA, MHRA, FDA, and CDC |
| V-safe |
| Vaccine Adverse Event Reporting System (VAERS) Standard Operating Procedures for COVID-19 |
| Vaccines and Related Biological Products Advisory Committee, remarks by Dr. Jessica Rose |
| VigiAccess |
| Who wants to be a Millionaire? |
